Page 1

Sales EPS Total Cooper Companies Fiscal 2022 financial guidance CooperVision Non - GAAP Cooper Companies FY22 Guidance * $ 3,032 $ 3,090 CooperSurgical $ 807 - $ 823 $ 2,225 $ 2,267 $ 13.60 $ 14.00 Growth vs. FY21 6 % -8 % cc 6 % -8 % cc 6 % -8 % cc 9.5 % -12.5 % cc Note : Sales $ in millions ; cc means constant currency ; Non - GAAP and cc - Refer to earnings release for definitions and reconciliation of results ; * Guidance as initiated 12/2/21 . FY22 guidance does not include the Generate Life Sciences acquisition announced 11/10/21 . 1